Synmosa Biopharma Market Cap

Synmosa Biopharma has a market cap or net worth of 18.10 billion as of August 15, 2025. Its market cap has increased by 16.98% in one year.

Market Cap

18.10B

Enterprise Value

18.73B

Revenue

6.00B

Ranking

n/a

PE Ratio

23.80

Stock Price

36.15

Market Cap Chart

Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 18.10B, an increase of 3,002.19%. That is a compound annual growth rate of 19.49%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	18.10B	24.84%
Dec 31, 2024	14.50B	-1.41%
Dec 29, 2023	14.71B	-8.20%
Dec 30, 2022	16.02B	128.36%
Dec 30, 2021	7.02B	2.96%
Dec 31, 2020	6.81B	20.87%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	210.16B
PharmaEssentia	167.97B
Bora Pharmaceuticals Co., LTD.	98.29B
Lotus Pharmaceutical	52.73B
Oneness Biotech	34.00B
Lumosa Therapeutics	28.78B
Polaris Group	27.23B
Center Laboratories	26.78B

Market Cap Rankings